Jean-Pierre Sommadossi, President, CEO, and Chairman at Atea Pharmaceuticals, Inc. (AVIR), sold 113,820 shares at $3.85 ($438K) on 2024-02-01, disclosed to the SEC on 2024-02-02.
Scheduled sale ($438k) by President, CEO, and Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.85 | 56,910 | $219K | 50.0% |
| 2 | $3.85 | 56,910 | $219K | 50.0% |
| Total | $3.85 avg | 113,820 | $438K | 100% |
| Filing → |
| IDIX | BUY | 2006-05-11 | $91K | — | Filing → |